PetMed Express (PETS)
(Delayed Data from NSDQ)
$3.90 USD
+0.04 (1.04%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $3.90 0.00 (0.00%) 7:58 PM ET
1-Strong Buy of 5 1
B Value C Growth D Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$3.90 USD
+0.04 (1.04%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $3.90 0.00 (0.00%) 7:58 PM ET
1-Strong Buy of 5 1
B Value C Growth D Momentum B VGM
Zacks News
Patterson Companies Dental Business Dull, Competition Rife
by Zacks Equity Research
Patterson's (PDCO) dental segment sales have been weak. The company faces stiff competition from at least 15 full-service distributors and small distributors.
Align Teams Up with Exocad to Expand in Digital Scanning
by Zacks Equity Research
Align's (ALGN) collaboration with CAD/CAM software provider, Exocad GmbH, is likely to integrate the Chairside CAD software into Align's iTero Element intraoral scanner.
Hologic (HOLX) Focuses on Breast Health, Ties Up with Clarius
by Zacks Equity Research
Hologic (HOLX) forges ahead with its efforts to strengthen hold in the high potential breast cancer screening market.
Hologic's FDA Nod for Quantra Software Boosts Breast Health
by Zacks Equity Research
Hologic (HOLX) is consistently trying to boost its Breast Health segment.
Alibaba (BABA) Announces Proposed Offering of Senior Notes (Revised)
by Zacks Equity Research
Alibaba Group Holding Limited (BABA) announces plans of offering senior unsecured notes. The move will help the company bring down its cost of capital, thereby strengthening its balance sheet.
The Zacks Analyst Blog Highlights: EVINE Live, ASOS, PetMed Express, Groupon, Amazon and Adobe Systems
by Zacks Equity Research
The Zacks Analyst Blog Highlights: EVINE Live, ASOS, PetMed Express, Groupon, Amazon and Adobe Systems
Add These 4 Promising Stocks to Your Cyber Monday Cart
by Zacks Equity Research
Cyber Monday is expected to be the largest online shopping fiesta of all times, courtesy upbeat job data and record low unemployment rate.
Here's Why You Should Add Amedisys (AMED) to Your Portfolio
by Zacks Equity Research
Strength in Hospice and Personal Care businesses offset the weakness in Amedisys' (AMED) Home Health Medicare business.
Here's Why You Should Invest in Masimo (MASI) Right Now
by Zacks Equity Research
Masimo (MASI) continues to grow on innovation and product launches.
Luminex (LMNX) at 52-Week High: What's Driving the Stock?
by Zacks Equity Research
Luminex (LMNX) gains from recent FDA approvals and product launches.
Zimmer Biomet Hurt by Supply Delay, Knee Challenges Remain
by Zacks Equity Research
Zimmer Biomet (ZBH) struggles with supply delay problem related to some of its products, causing inability to win back lost customers and gain new ones.
Here's Why You Should Invest in Align Technology (ALGN) Now
by Zacks Equity Research
Align Technology (ALGN) continues to boost investors' confidence on consistent strength in InvisAlign.
PetMed (PETS) Down 7.8% Since Earnings Report: Can It Rebound?
by Zacks Equity Research
PetMed (PETS) reported earnings about a month ago. What's next for the stock? We take a look at earnings estimates for some clues.
AmerisourceBergen to Take Over H. D. Smith for $815 Million
by Zacks Equity Research
AmerisourceBergen (ABC) strives to strengthen core businesses. The H. D. Smith buyout is likely to strengthen the Pharmaceutical Distribution Segment.
DexCom-Lily Partnership to Boost CGM Platform, Customer Base
by Zacks Equity Research
DexCom (DXCM) continues to sign deals to boost CGM platform adoption.
Here's Why You Should Offload Fresenius Medical Stock Now
by Zacks Equity Research
Fresenius (FMS) grapples with multiple issues. An unfavorable estimate revision trend adds to the woes.
Varian to Open Facility in Brazil, Global Growth in Focus
by Zacks Equity Research
Varian's (VAR) strong overseas presence is likely to fortify its foothold in the emerging markets. The recent initiative would boost its presence in Latin America.
Rising Costs Hurt Henry Schein, End-Market Trends a Tailwind
by Zacks Equity Research
Higher cost of sales and expenses hurt Henry Schein's (HSIC) gross and operating margin. However, several end market trends like demographics are likely to benefit the company.
5 Cheap Dividend Growth Stocks for Thanksgiving
by Sweta Killa
Stuff dividend stocks with strong growth prospects in your portfolio for market-beating returns this Thanksgiving Day.
Medtronic (MDT) Beats on Q2 Earnings, Reiterates FY18 View
by Zacks Equity Research
Medtronic (MDT) rides high on strength in major business segments in Q2.
Patterson Companies (PDCO) Misses on Q2 Earnings, Cuts View
by Zacks Equity Research
Patterson Companies (PDCO) missed estimates for both the counts in Q2. A downbeat guidance indicates looming concerns.
Medtronic Wins FDA Nod for Azure Pacemakers, Grows in CVG
by Zacks Equity Research
Medtronic (MDT) strives to improve its Cardiac Rhythm and Heart Failure division.
DENTSPLY SIRONA Strong on Deal Renewals, Forex Woes Stay
by Zacks Equity Research
DENTSPLY SIRONA's (XRAY) renewed distribution deal will help the company gain market traction. However, forex woes remain a concern.
McKesson Gains From Distribution Business Amid Pricing Woes
by Zacks Equity Research
McKesson Corporation's (MCK) Distribution business is driven by market growth and acquisitions. However, pricing remains a concern.
Haemonetics (HAE) at 52-Week High: What's Driving the Stock?
by Zacks Equity Research
Haemonetics (HAE) focuses on development and launch of NexSys PCS plasmapheresis system.